OVERVIEW
The Artificial Intelligence in Infectious Disease Workshop 2024 will be held virtually on 5-6 December 2024. Registration is complimentary for all regular delegates until 21 November 2024.

This international workshop is a novel initiative designed to foster collaboration between healthcare professionals and the artificial intelligence (AI) technology sector. It aims to bridge the gap between cutting-edge AI advancements and practical clinical applications, encouraging clinicians to step into the digital age and embrace AI to propel medicine into the future. By facilitating the exchange of knowledge through abstract and application "pitch" submissions, the workshop provides a unique platform for providers to quickly understand and adapt to the latest developments. This dynamic platform will kick-start a lasting partnership between infectious disease medicine and AI technology, ultimately enhancing patient care and improving clinical outcomes.

The workshop focuses on the effective use of AI in managing infectious diseases. Given the rapid advancements in AI and its profound current and potential impact on healthcare, the workshop is designed to be a space where researchers and medical professionals can discuss and collaborate on translating research findings into clinical practice. Additionally, the event aims to address the associated risks and opportunities of implementing AI in infectious disease management, ensuring a comprehensive understanding of the technology's potential and its challenges. By emphasizing human-machine teaming, the workshop seeks to augment the practice style of clinicians, not replace their clinical decision-making.

This revolutionary workshop aims to accelerate research, improve clinical care, and build lasting collaborations. It will not only advance the integration of AI into infectious disease medicine but also pave the way for future innovations in patient care. By bringing together experts from both the AI and medical fields, the workshop will serve as a catalyst for breakthroughs that can transform the landscape of healthcare, making it more efficient, effective, and responsive to emerging challenges. 

LEARNING OBJECTIVES
• Gain insights into the newest AI advancements and how they can be applied to the field of infectious disease.
• Learn how AI can augment clinical decision-making processes and enhance the practice style of clinicians without replacing their expertise.
• Explore ways to expedite research through AI, enabling faster identification, diagnosis, and treatment of infectious diseases.
• Foster partnerships between AI technology companies and healthcare providers to drive innovation and improve the integration of AI in clinical settings.
• Discuss methods for effectively translating AI research and developments into practical, real-world applications in infectious disease care.
• Analyze the potential risks and benefits associated with implementing AI in infectious disease management, including ethical considerations and data security.

TARGET AUDIENCE
• Forward-thinking healthcare providers involved in the care of people with infectious diseases
• Academic researchers from the biomedical and AI sectors
• Residents, post-graduates, and PhD students
• Government agency personnel, policymakers, NGO representatives, and health authority personnel
• Social workers, advocates, and community workers
• Emerging and established medical technologists and industry representatives

ACCREDITATION
The Artificial Intelligence in Infectious Disease Workshop 2024, Amsterdam, Netherlands, 05/12/2024 - 06/12/2024, has been accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) with 9.0 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the Union Européenne des Médecins Spécialistes and the American Medical Association, physicians may convert EACCME® credits to an equivalent number of AMA PRA Category 1 CreditsTM. Information on the process to convert EACCME® credit to AMA credit can be found at https://edhub.ama-assn.org/pages/applications.

Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME® for ECMEC®s are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

For more information please visit the official event page.